Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...

Avisi Technologies’ investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).

Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring the importance of a thorough evaluation.

Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19 ...

The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...

Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...

The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...

Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...

The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...

The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...